2026 Global: Cell Freezing Media For Cell Therapy Market -Competitive Review (2032) report
Description
The 2026 Global: Cell Freezing Media For Cell Therapy Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cell freezing media for cell therapy market by geography and historical trend. The scope of the report extends to sizing of the cell freezing media for cell therapy market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Thermo Fisher Scientific Inc. dominates the cell freezing media for cell therapy market with its comprehensive cryopreservation solutions, including GIBCO™ recovery cell culture freezing medium featuring balanced DMSO concentrations for optimal cell viability. Merck KGaA follows closely, offering innovative, high-quality freezing media tailored for pharmaceutical and biotechnological applications, emphasizing scalability and regulatory compliance in cell therapy preservation. Sartorius AG provides advanced bioprocessing cryopreservation media, leveraging its expertise in biomanufacturing to support diverse cell types used in regenerative medicine and clinical trials. BioLife Solutions Inc. specializes in hypothermic storage and cryopreservation formulations, delivering innovative products that maintain cell potency for cell therapy workflows.
HiMedia Laboratories stands out with cost-effective, high-quality freezing media, gaining international traction through its focus on advanced cell preservation for emerging biotechnology sectors in India and beyond. Bio-Techne supplies specialized freezing media within its cell biology portfolio, catering to research and therapeutic applications requiring consistent viability post-thaw. Capricorn Scientific emphasizes reliability in its high-quality cell culture and cryopreservation products, supporting biobanking and cell therapy development across Europe. PromoCell GmbH offers primary cell culture solutions with tailored preservation media, optimized for stem cells and immune cells in therapy contexts.
STEMCELL Technologies Inc. excels in high-performance freezing media for stem cell biology and regenerative medicine, backed by its global leadership in cell separation and culture tools. Lonza Group Ltd. contributes premium, chemically defined cryopreservation solutions like TheraPEAK™, designed for clinical-grade cell therapy expansion and storage. AMSBIO rounds out the top ten with specialized media preserving therapeutic cell properties, aiding clinical approvals and trials in the burgeoning cell therapy landscape. These companies collectively drive market growth from USD 1.3 billion in 2025 to USD 2.9 billion by 2035, fueled by rising regenerative medicine demands.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cell freezing media for cell therapy market by geography and historical trend. The scope of the report extends to sizing of the cell freezing media for cell therapy market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Thermo Fisher Scientific Inc. dominates the cell freezing media for cell therapy market with its comprehensive cryopreservation solutions, including GIBCO™ recovery cell culture freezing medium featuring balanced DMSO concentrations for optimal cell viability. Merck KGaA follows closely, offering innovative, high-quality freezing media tailored for pharmaceutical and biotechnological applications, emphasizing scalability and regulatory compliance in cell therapy preservation. Sartorius AG provides advanced bioprocessing cryopreservation media, leveraging its expertise in biomanufacturing to support diverse cell types used in regenerative medicine and clinical trials. BioLife Solutions Inc. specializes in hypothermic storage and cryopreservation formulations, delivering innovative products that maintain cell potency for cell therapy workflows.
HiMedia Laboratories stands out with cost-effective, high-quality freezing media, gaining international traction through its focus on advanced cell preservation for emerging biotechnology sectors in India and beyond. Bio-Techne supplies specialized freezing media within its cell biology portfolio, catering to research and therapeutic applications requiring consistent viability post-thaw. Capricorn Scientific emphasizes reliability in its high-quality cell culture and cryopreservation products, supporting biobanking and cell therapy development across Europe. PromoCell GmbH offers primary cell culture solutions with tailored preservation media, optimized for stem cells and immune cells in therapy contexts.
STEMCELL Technologies Inc. excels in high-performance freezing media for stem cell biology and regenerative medicine, backed by its global leadership in cell separation and culture tools. Lonza Group Ltd. contributes premium, chemically defined cryopreservation solutions like TheraPEAK™, designed for clinical-grade cell therapy expansion and storage. AMSBIO rounds out the top ten with specialized media preserving therapeutic cell properties, aiding clinical approvals and trials in the burgeoning cell therapy landscape. These companies collectively drive market growth from USD 1.3 billion in 2025 to USD 2.9 billion by 2035, fueled by rising regenerative medicine demands.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.